N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide

This compound is a synthetic small molecule dipeptide derivative with the formula C26H33F3N4O7. It is known as an experimental inhibitor of chymotrypsin-like elastase family member CELA1 (chymotrypsin-like elastase family member I), a serine protease involved in the degradation of elastin and other proteins. The compound has not been approved for any clinical use and has no reported indications or completed clinical trials. Its primary mechanism of action is inhibition of CELA1 activity[6][7]. No additional pharmacological or therapeutic information is available.

Other names

2-((4-(((2S)-3-methyl-1-oxo-1-((2S)-2-( ((3S)-1,1,1-trifluoro - 4 - methyl - 2 - oxopentan - 3 - yl ) carbamoyl ) pyrrolidin - 1 - yl ) butan - 2 - yl ) carbamoyl ) phenyl ) formamido)acetic acidN-(4-( (Carboxymethyl)carbamoyl)benzoyl)-L-valyl-N-( (3S)- 1 , 1 , 1-trifluoro – 4 – methyl – 2 – oxo – 3 – pentanyl )– L–prolinamideMetabolomics Workbench ID148196